| J0897 | Injection, denosumab, 1 mg | 6,180 | $20 | $111.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 820 | $100 | $82K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 5,670 | $10 | $45.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 2,950 | $10 | $29.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 820 | $30 | $21.3K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 590 | $30 | $15.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 110 | $130 | $14K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 170 | $80 | $13.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $120 | $11.3K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 2,130 | $10 | $10.6K |